TCRT - Why Is Alaunos Therapeutics (TCRT) Stock Up 37% Today?
2023-12-18 07:57:12 ET
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Alaunos Therapeutics (NASDAQ: TCRT ) stock is up on Monday despite a lack of news from the clinical-stage oncology-focused cell therapy company .
There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today. On that same note, no analysts are offering new coverage of the shares.
What we do know is that TCRT stock is experiencing incredibly heavy trading on Monday morning. As of this writing, more than 49 million shares of the stock have changed hands. That’s a massive gain compared to its daily average trading volume of about 3.6 million shares.
One thing that traders will want to keep in mind is that TCRT is a penny stock. That comes from Alaunos Therapeutics’ prior closing price of just 5 cents and its market capitalization of only about $10.949 million.
Why That Matters to TCRT Stock
Being a penny stock opens Alaunos Therapeutics up to certain vulnerabilities. That includes volatility as retail and day traders pump the stock.
Of course, this also means those same traders might dump the stock in the near future once the rally has peaked. That makes jumping into TCRT stock a risky investment right now.
TCRT stock is up 36.9% as of Monday morning. The stock was down 92.8% year-to-date as of Friday’s close.
Investors seeking out more of the hottest stock market stories will want to stick around!
We have all of the latest market news worth reading about on Monday! That includes the biggest pre-market stock movers this morning, the latest news concerning the congressional budget and more. You can find out more on these matters at the following links!
More Monday Stock Market News
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
- Good News! The Congressional Budget Office Says a Soft Landing Is Here.
- Why Are Chip Stocks Up Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that?InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines .
More From InvestorPlace
- ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
- Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
- The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Why Is Alaunos Therapeutics (TCRT) Stock Up 37% Today? appeared first on InvestorPlace .